Streamline Total Liab from 2010 to 2025
| STRM Stock | USD 4.60 0.09 2.00% |
Total Liabilities | First Reported 1996-01-31 | Previous Quarter 23.1 M | Current Value 22.1 M | Quarterly Volatility 9 M |
Check Streamline Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Streamline Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 M, Total Revenue of 19.1 M or Gross Profit of 9.9 M, as well as many indicators such as Price To Sales Ratio of 1.07, Dividend Yield of 0.0 or PTB Ratio of 1.28. Streamline financial statements analysis is a perfect complement when working with Streamline Health Valuation or Volatility modules.
Streamline | Total Liab |
Latest Streamline Health's Total Liab Growth Pattern
Below is the plot of the Total Liab of Streamline Health Solutions over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Streamline Health's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Streamline Health's overall financial position and show how it may be relating to other accounts over time.
| Total Liab | 10 Years Trend |
|
Total Liab |
| Timeline |
Streamline Total Liab Regression Statistics
| Arithmetic Mean | 21,679,425 | |
| Geometric Mean | 19,138,031 | |
| Coefficient Of Variation | 38.25 | |
| Mean Deviation | 6,477,154 | |
| Median | 23,054,000 | |
| Standard Deviation | 8,292,287 | |
| Sample Variance | 68.8T | |
| Range | 31.3M | |
| R-Value | 0.04 | |
| Mean Square Error | 73.5T | |
| R-Squared | 0 | |
| Significance | 0.88 | |
| Slope | 72,454 | |
| Total Sum of Squares | 1031.4T |
Streamline Total Liab History
About Streamline Health Financial Statements
Streamline Health investors utilize fundamental indicators, such as Total Liab, to predict how Streamline Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Liabilities | 26.4 M | 16.6 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Streamline Health Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (2.35) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.